“…In our previous study, using gas chromatography time-of-flight mass spectrometry and a variety of multivariate statistical methods, including PCA, PLS-DA and OPLS-DA, it was confirmed that L-dopa, 1,4-dihydroxy-2-naphthoic acid and tartronic acid, which are primarily associated with amino acid, glycogen metabolism and the TCA cycle, were markedly altered (46,47). In the present study, it was found that certain genes were significantly altered in the animal model group, including transmembrane 6 superfamily member 2, monoacylglycerol O-acyltransferase, ATP citrate lyase and angiopoietin-like 4, which are related to lipid metabolism (48,49), glycogen synthase 2, dihydrolipoamide S-acetyltransferase, glucagon receptor and pyruvate dehydrogenase E1 beta subunit, which are important in several biological functions including glycogen metabolic process and response to glucose (50,51), and aconitase 1, which is involved in TAC (52,53), indicating there were some metabolic disorders during the development of RA, which is consistent with our previous studies (46,47). Following the administration of AST, the expression of these genes returned to normal levels, indicating that AST can regulate disorders of metabolism.…”